the 'Région Languedoc-Roussillon' (France) (to SD), the 'Agence Française de Biomedecine', the 'Société d'Accélération du Transfert de Technologies' Languedoc Roussillon (SATT, AxLR) (to SD) and by the Grant TPLIRBCELL (ANR-2010-BLANC-1117-01) from the 'Agence Nationale de la Recherche, INSERM and the SARL 'Médecine-Biologie-Méditerannée', pp.31-2008 ,
Mechanisms of pancreatic ?cell death in type 1 and type 2 diabetes: many differences, few similarities, Diabetes, vol.54, pp.97-107, 2005. ,
Improvement in outcomes of clinical islet transplantation: 1999-2010, Diabetes Care, vol.35, pp.1436-1445, 2012. ,
Five-year metabolic, functional, and safety results of patients with type 1 diabetes transplanted with allogenic islets within the Swiss-French GRAGIL Network, Diabetes Care, vol.38, pp.1714-1722, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01850555
Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts, J Leukoc Biol, vol.77, pp.587-597, 2005. ,
Interleukin-1 antagonists and other cytokine blockade strategies for type 1 diabetes, Rev Diabet Stud, vol.9, pp.338-347, 2012. ,
Cytokine production by islets in health and diabetes: cellular origin, regulation and function, Trends Endocrinol Metab, vol.21, pp.261-267, 2010. ,
TNF-alpha and IFN-gamma potentiate the deleterious effects of IL-1 beta on mouse pancreatic islets mainly via generation of nitric oxide, Cytokine, vol.6, pp.399-406, 1994. ,
Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture, J Clin Endocrinol Metab, vol.71, pp.152-156, 1990. ,
The central role of calcium in the effects of cytokines on beta-cell function: implications for type 1 and type 2 diabetes, Cell Calcium, vol.50, pp.481-490, 2011. ,
Antiinflammatory properties of exenatide in human pancreatic islets, Cell Transplant, vol.21, pp.633-648, 2012. ,
Long-term insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept, Transplantation, vol.86, pp.1658-1665, 2008. ,
GLP-1 receptor signaling protects pancreatic beta cells in intraportal islet transplant by inhibiting apoptosis, Biochem Biophys Res Commun, vol.367, pp.793-798, 2008. ,
Use of glucagon-like peptide-1 agonists to improve islet graft performance, Curr Diab Rep, vol.13, pp.723-732, 2013. ,
Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets, Endocrinology, vol.144, pp.5149-5158, 2003. ,
Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B, Diabetologia, vol.48, pp.1339-1349, 2005. ,
Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells, Endocrinology, vol.148, pp.5136-5144, 2007. ,
ERK1/2 control phosphorylation and protein level of cAMP-responsive element-binding protein: a key role in glucose-mediated pancreatic beta-cell survival, Diabetes, vol.55, pp.2220-2230, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00201283
A p21-activated kinase (PAK1) signaling cascade coordinately regulates F-actin remodeling and insulin granule exocytosis in pancreatic ? cells, Biochem Pharmacol, vol.85, pp.808-816, 2013. ,
GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1/2 activation in pancreatic beta-cells, J Biol Chem, vol.285, pp.1989-2002, 2010. ,
Tpl2/cot signals activate ERK, JNK, and NF-kappaB in a cell-type and stimulus-specific manner, J Biol Chem, vol.280, pp.23748-23757, 2005. ,
IkappaB kinase regulation of the TPL-2/ ERK MAPK pathway, Immunol Rev, vol.246, pp.168-182, 2012. ,
Tpl2 Kinase is upregulated in adipose tissue in obesity and may mediate interleukin-1? and tumor necrosis factor-? effects on extracellular signal-regulated kinase activation and lipolysis, Diabetes, vol.59, pp.61-70, 2010. ,
Tpl-2 induces apoptosis by promoting the assembly of protein complexes that contain caspase-9, the adapter protein Tvl-1, and procaspase-3, J Cell Physiol, vol.187, pp.176-187, 2001. ,
Serine/threonine kinase, Cot/Tpl2, regulates renal cell apoptosis in ischaemia/reperfusion injury, Nephrology, vol.13, pp.397-404, 2008. ,
Lipopolysaccharide activation of the TPL-2/ MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IkappaB kinase-induced proteolysis of NF-kappaB1 p105, Mol Cell Biol, vol.24, pp.9658-9667, 2004. ,
Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IkappaB Kinase 2, TPCA-1 (2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell Proliferation, J Pharmacol Exp Ther, vol.312, pp.373-381, 2005. ,
Control of instant blood-mediated inflammatory reaction to improve islets of Langerhans engraftment, Current Opin Organ Transplant, vol.16, pp.620-626, 2011. ,
The role of tumor progression locus 2 protein kinase in glial inflammatory response, J Neurochem, vol.128, pp.919-926, 2014. ,
Growth arrest-and DNA-damage-inducible 45beta gene inhibits c-Jun N-terminal kinase and extracellular signal-regulated kinase and decreases IL-1beta-induced apoptosis in insulinproducing INS-1E cells, Diabetologia, vol.49, pp.980-989, 2006. ,
Extracellular signal-regulated kinase is essential for interleukin-1-induced and nuclear factor kappaBmediated gene expression in insulin-producing INS-1E cells, Diabetologia, vol.48, pp.2582-2590, 2005. ,
Glucose-and interleukin-1beta-induced beta-cell apoptosis requires Ca2+ influx and extracellular signalregulated kinase (ERK) 1/2 activation and is prevented by a sulfonylurea receptor 1/inwardly rectifying K+ channel 6.2 (SUR/Kir6.2) selective potassium channel opener in human islets, Diabetes, vol.53, pp.1706-1713, 2004. ,
Activation of extracellular signalregulated kinase (ERK)1/2 contributes to cytokine-induced apoptosis in purified rat pancreatic beta-cells, Eur Cytokine Netw, vol.11, pp.267-274, 2000. ,
Role of p38 mitogen-activated protein kinase (p38 MAPK) in cytokine-induced rat islet cell apoptosis1, Biochem Pharmacol, vol.61, pp.1561-1569, 2001. ,
Induction of nuclear factor-kappaB and its downstream genes by TNF-alpha and IL-1beta has a pro-apoptotic role in pancreatic beta cells, Diabetologia, vol.51, pp.1213-1225, 2008. ,
Cot/tpl2 activity is required for TLR-induced activation of the Akt p70 S6k pathway in macrophages: Implications for NO synthase 2 expression, Eur J Immunol, vol.41, pp.1733-1741, 2011. ,
Altered prostanoid signaling contributes to increased skin tumorigenesis in Tpl2 knockout mice, PLoS One, vol.8, p.56212, 2013. ,
Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4, Diabetes, vol.53, pp.1700-1705, 2004. ,
Exendin-4 protects pancreatic beta cells from the cytotoxic effect of rapamycin by inhibiting JNK and p38 phosphorylation, Horm Metab Res, vol.42, pp.311-317, 2010. ,
Prostaglandin E2 receptor, EP3, is induced in diabetic islets and negatively regulates glucose-and hormone-stimulated insulin secretion, Diabetes, vol.62, pp.1904-1912, 2013. ,
COX-2 inhibition prevents insulindependent diabetes in low-dose streptozotocin-treated mice, Biochem Biophys Res Commun, vol.273, pp.699-704, 2000. ,
Inhibition of interleukin-1beta-induced COX-2 and EP3 gene expression by sodium salicylate enhances pancreatic islet beta-cell function, Diabetes, vol.51, pp.1772-1778, 2002. ,
The Tpl2 kinase regulates the COX-2/prostaglandin E2 axis in adipocytes in inflammatory conditions, Mol Endocrinol, vol.29, pp.1025-1036, 2015. ,
Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals, EMBO J, vol.21, pp.4831-4840, 2002. ,
Targeting inflammation in the treatment of type 2 diabetes: time to start, Nat Rev Drug Discov, vol.13, pp.465-476, 2014. ,
Inhibition of Tpl2 kinase and TNFalpha production with quinoline-3-carbonitriles for the treatment of rheumatoid arthritis, Bioorg Medic Chem Lett, vol.16, pp.6067-6072, 2006. ,
Genetic and pharmacological targeting of TPL-2 kinase ameliorates experimental colitis: a potential target for the treatment of Crohn's disease?, Mucosal Immunol, vol.5, pp.129-139, 2012. ,
Cot/tpl2 (MAP3K8) mediates myeloperoxidase activity and hypernociception following peripheral inflammation, J Biol Chem, vol.285, pp.33805-33815, 2010. ,
beta-Arrestin 1 is required for PAC1 receptor-mediated potentiation of long-lasting ERK1/2 activation by glucose in pancreatic beta-cells, J Biol Chem, vol.284, pp.4332-4342, 2009. ,
Assessment of a novel two-component enzyme preparation for human islet isolation and transplantation, Transplantation, vol.79, pp.91-97, 2005. ,
?-Arrestin2 plays a key role in the modulation of the pancreatic beta cell mass in mice, Diabetologia, vol.57, pp.532-541, 2014. ,
, Cell Death and Disease is an open-access journal published by